Published in Br J Cancer on April 01, 2000
Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res (2000) 1.50
BRCA1 variants in a family study of African-American and Latina women. Hum Genet (2005) 1.19
Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci. Am J Hum Genet (2009) 0.99
Genetics of disc-related disorders: current findings and lessons from other complex diseases. Eur Spine J (2013) 0.98
MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours. Br J Cancer (2013) 0.97
Breast feeding, parity and breast cancer subtypes in a Spanish cohort. PLoS One (2012) 0.92
Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics. J Med Genet (2003) 0.90
Family history and breast cancer hormone receptor status in a Spanish cohort. PLoS One (2012) 0.88
Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet (2008) 0.87
Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing. Fam Cancer (2015) 0.82
The pathology of hereditary breast cancer. Hered Cancer Clin Pract (2004) 0.81
Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer. Cancer Epidemiol Biomarkers Prev (2014) 0.78
Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model. Oncotarget (2016) 0.75
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (1994) 36.53
Identification of the breast cancer susceptibility gene BRCA2. Nature (1996) 17.14
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1998) 15.09
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01
BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med (1997) 4.33
Rapid detection of BRCA1 mutations by the protein truncation test. Nat Genet (1995) 3.61
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet (1994) 3.38
Population genetics of BRCA1 and BRCA2. Am J Hum Genet (1997) 3.28
Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet (1997) 2.15
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet (1994) 1.88
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet (1997) 1.60
BRCA1 and BRCA2: from molecular genetics to clinical medicine. J Clin Oncol (1998) 1.52
Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. Hum Mol Genet (1995) 1.22
Familial breast cancer and its recognition in an oncology clinic. Cancer (1981) 0.96
Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. Br J Cancer (1999) 0.96
Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations. J Clin Oncol (1998) 0.84
Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast/ovarian cancer families. Cancer Lett (1998) 0.83
Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population. Hum Genet (1998) 0.83
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study. J Clin Oncol (2005) 1.86
Molecular characterisation of a common SDHB deletion in paraganglioma patients. J Med Genet (2007) 1.86
Ulceration of the palate caused by a basidiomycete Schizophyllum commune. Sabouraudia (1973) 1.85
Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet Cytogenet (2003) 1.70
An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res (2012) 1.62
Observational study of continuous spinal anesthesia with the catheter-over-needle technique for cesarean delivery. Int J Obstet Anesth (2009) 1.53
SLC45A2: a novel malignant melanoma-associated gene. Hum Mutat (2008) 1.50
Association of G-protein-coupled receptor 154 with asthma and total IgE in a population of the Caribbean coast of Colombia. Clin Exp Allergy (2009) 1.49
Bacteriophages and their application in food safety. Lett Appl Microbiol (2008) 1.49
True histiocytic lymphoma (monocytic sarcoma) Am J Dermatopathol (1992) 1.45
The 12 base pair duplication/insertion alteration could be a regulatory mutation. J Med Genet (1997) 1.44
Characterization of the collagen-binding S-layer protein CbsA of Lactobacillus crispatus. J Bacteriol (2000) 1.43
Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia. Haematologica (2001) 1.41
[Prevalence of Factor V Leiden and the G20210A mutation of the prothrombin gene in a random group of patients with thrombotic episodes]. Sangre (Barc) (1999) 1.39
Global budgets and excess demand for hospital care. Health Econ (1997) 1.39
[Morbid obesity: surgical treatment (II). Current bariatric techniques, efficacy and legal implications]. Med Clin (Barc) (1991) 1.39
[Comparative study of the survival of gastric B-cell lymphoma of mucosal origin with respect to lymph node lymphoma of similar histology]. Med Clin (Barc) (1992) 1.39
[Reactive arthritis from Giardia intestinalis]. Med Clin (Barc) (1991) 1.38
[Comparison of 2 techniques for combined spinal-epidural analgesia for advanced labor in childbirth]. Rev Esp Anestesiol Reanim (2006) 1.37
Classification of missense variants of unknown significance in BRCA1 based on clinical and tumor information. Hum Mutat (2007) 1.33
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33
Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology (2010) 1.30
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J (2009) 1.28
Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Oncogene (2007) 1.28
The molecular pathology of hereditary breast cancer. Pathobiology (2008) 1.25
Results of surgical treatment of hepatic hydatidosis: current therapeutic modifications. World J Surg (1991) 1.22
Paracoccidioidomycosis, (South American blastomycosis). A study of 39 cases observed in Medellin, Colombia. Am J Trop Med Hyg (1970) 1.17
Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther (1995) 1.15
Distribution of paracoccidioidin sensitivity in Colombia. Am J Trop Med Hyg (1968) 1.15
Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas. Leukemia (2005) 1.14
Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer (2005) 1.14
Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information. Oncogene (2007) 1.13
Longitudinal analysis of metalloproteinases, tissue inhibitors of metalloproteinases and clinical parameters in gingival crevicular fluid from periodontitis-affected patients. J Periodontal Res (2005) 1.12
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity. Pharmacogenomics J (2010) 1.10
Lhermitte-Duclos disease and Cowden disease: clinical and genetic study in five patients with Lhermitte-Duclos disease and literature review. Acta Neurochir (Wien) (2004) 1.10
Pathogenesis of paracoccidioidomycosis: a model based on the study of 46 patients. Mycopathologia (1976) 1.09
Inhibition of apoptosis by the African swine fever virus Bcl-2 homologue: role of the BH1 domain. Virology (1997) 1.09
Effect of frozen storage conditions (temperature and length of storage) on microbiological and sensory quality of rustic crossbred beef at different states of ageing. Meat Sci (2009) 1.08
[Sneddon's syndrome: its clinical characteristics and etiopathogenic factors]. Rev Clin Esp (1992) 1.07
MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis (2007) 1.06
Homozygous tandem duplication within the gene encoding the beta-subunit of rod phosphodiesterase as a cause for autosomal recessive retinitis pigmentosa. Hum Mutat (1995) 1.05
The gamut of paracoccidioidomycosis. Am J Med (1976) 1.05
Delayed neutrophil apoptosis in chronic periodontitis patients. J Clin Periodontol (2003) 1.05
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene (2012) 1.05
Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism. FEBS Lett (1999) 1.04
Cellular senescence bypass screen identifies new putative tumor suppressor genes. Oncogene (2007) 1.03
Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families. Hum Genet (1995) 1.02
Estrogen and progesterone receptor gene polymorphisms and sporadic breast cancer risk: a Spanish case-control study. Int J Cancer (2006) 1.02
A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. Hum Mutat (2006) 1.02
Prevalence of bacteriophages infecting Staphylococcus aureus in dairy samples and their potential as biocontrol agents. J Dairy Sci (2009) 1.01
Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol (1998) 1.01
Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma. Ann Oncol (2013) 1.01
Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics (1996) 1.00
[The Pro347Leu mutation of the rhodopsin gene in a Spanish family with autosomal dominant pigmentary retinosis]. Med Clin (Barc) (1998) 0.99
MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis. Br J Cancer (2013) 0.99
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr Scand (1993) 0.99
Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists. Clin Pharmacol Ther (1999) 0.99
Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol (2004) 0.98
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism. Pharmacogenomics J (2007) 0.97
MicroRNA-based molecular classification of non-BRCA1/2 hereditary breast tumours. Br J Cancer (2013) 0.97
FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. Br J Cancer (2014) 0.96
Cytogenetic recombinants from a female carrying a paracentric inversion of the short arm of chromosome number 5. Hum Genet (1983) 0.96
Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. Br J Cancer (1999) 0.96
Acetylator polymorphism in human colorectal carcinoma. Cancer Res (1991) 0.95
Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia (1997) 0.95
HIV/STI co-infection among men who have sex with men in Spain. Euro Surveill (2009) 0.94
Ketoconazole: a new drug for the treatment of paracoccidioidomycosis. Rev Infect Dis (1981) 0.93
FANCD2 associated with sporadic breast cancer risk. Carcinogenesis (2006) 0.93
IgH, TCR-gamma, and TCR-beta gene rearrangement in 80 B- and T-cell non-Hodgkin's lymphomas: study of the association between proliferation and the so-called "aberrant" patterns. Diagn Mol Pathol (2001) 0.92
Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother (1994) 0.92
Simultaneous detection of the immunophenotypic markers and genetic aberrations on routinely processed paraffin sections of lymphoma samples by means of the FICTION technique. Leukemia (2004) 0.91
Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics (1995) 0.91
Genetic and epigenetic profile of sporadic pheochromocytomas. J Med Genet (2004) 0.90
Clinical and genetic characterization of classical forms of familial adenomatous polyposis: a Spanish population study. Ann Oncol (2010) 0.90
CYP2D6 genes and risk of liver cancer. Lancet (1995) 0.90
RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut (1996) 0.90
Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk. Br J Cancer (1998) 0.89
Pharmacokinetic-Pharmacodynamic Modelling of the antipyretic effect of two oral formulations of ibuprofen. Clin Pharmacokinet (2000) 0.89
Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways. Clin Pharmacol Ther (1994) 0.89
Association between FAS polymorphism and prostate cancer development. Prostate Cancer Prostatic Dis (2007) 0.88
Progressive deterioration of central components of auditory brainstem responses during postnatal development of the myelin mutant taiep rat. Audiol Neurootol (2000) 0.88
Are antipsychotic drugs potentially chemopreventive agents for cancer? Eur J Clin Pharmacol (1999) 0.88
Novel rhodopsin mutation in an autosomal dominant retinitis pigmentosa family: phenotypic variation in both heterozygote and homozygote Val137Met mutant patients. Hum Genet (1996) 0.88
Prevalence of urinary incontinence among Spanish older people living at home. Eur Urol (1998) 0.87
Trinucleotide (CAG) repeat expansion in chromosomes of Spanish patients with Huntington's disease. Hum Genet (1994) 0.87
ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia. Blood Cancer J (2013) 0.87
Nucleotide sequence and analysis of pBL1, a bacteriocin-producing plasmid from Lactococcus lactis IPLA 972. Plasmid (2000) 0.87
Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours. Ann Oncol (2003) 0.87
Host defense against experimental paracoccidioidomycosis. Am Rev Respir Dis (1982) 0.87
Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype. Eur J Drug Metab Pharmacokinet (1996) 0.87
Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sjogren's syndrome: association with mononuclear cell infiltration. Ann Rheum Dis (2005) 0.87